David Sackler and Kathe Sackler, along with Purdue Pharma CEO Craig Landau, will answer the committee’s questions about their role in the company’s operations and the company’s overall influence on the opioid epidemic.
The committee plans to review documents suggesting that some Sackler family members used the highly addictive painkiller OxyContin to grow revenue and “stretch” company financial targets, according to a Dec. 14 memo. The hearing will also include an examination of documents that show members of the Sackler family agreed to target high-volume prescribers and push higher strength doses.
More articles on opioids:
Biden’s plan to tackle the opioid epidemic: 5 things to know
McKinsey responds to role it played in OxyContin sales
10 most-read opioid stories in 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
